These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38814201)

  • 1. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
    Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
    J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
    Yu J; Zhu C; Yin J; Yu D; Wan F; Tang X; Jiang X
    Drug Des Devel Ther; 2020; 14():361-370. PubMed ID: 32095070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
    Kim EY; Roshanravan H; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
    Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
    Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.
    Anderson M; Kim EY; Hagmann H; Benzing T; Dryer SE
    Am J Physiol Cell Physiol; 2013 Aug; 305(3):C276-89. PubMed ID: 23657570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
    J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms.
    Fan Q; Zhang H; Ding J; Liu S; Miao J; Xing Y; Yu Z; Guan N
    Genes Cells; 2009 Sep; 14(9):1079-90. PubMed ID: 19674119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation-dependent activation of TRPC6 regulated by PLC-γ1 and nephrin: effect of mutations associated with focal segmental glomerulosclerosis.
    Kanda S; Harita Y; Shibagaki Y; Sekine T; Igarashi T; Inoue T; Hattori S
    Mol Biol Cell; 2011 Jun; 22(11):1824-35. PubMed ID: 21471003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
    Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
    J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
    Roshanravan H; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.